Short-term and long-term outcomes of indocyanine green for sentinel lymph node biopsy in early-stage breast cancer

Table 1 Clinical and pathological characters of the enrolled patients

Clinicopathological factors	N = 194	%
Age
≥ 65	64	32.99
< 65	130	67.01
Histological grade
G1	27	13.92
G2	112	57.73
G3	55	28.35
Estrogen receptor expression
Positive	155	79.90
Negative	39	20.10
Progesterone receptor expression
Positive	154	79.38
Negative	40	20.62
HER-2 expression
Positive	42	21.65
Negative	107	55.15
Unknown	45	23.20
Ki-67 proliferation index
≥ 14%	133	68.56
< 14%	61	31.44
pTNM stage
0	5	2.58
I	93	47.94
II	86	44.33
III	10	5.15
Pattern of surgery
SLNB + M	147	75.77
SLNB + MRM	38	19.59
SLNB +BCT	9	4.64

BCT Breast conserving therapy, HER-2 Human epidermal growth factor receptor 2, M Mastectomy, MRM Modified radical mastectomy, N Number, pTNM Pathological tumor-node metastasis, SLNB Sentinel lymph node biopsy

ISSN: 1477-7819